18f-fluoromethyltyrosine

Small moleculeexperimentalImaging agent

Clinical trial activity

2 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2010 (NCT01089998)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetRadiopharmaceutical

    radiopharmaceutical

Chemistry & pharmacology

Imaging
18-fluorine

Oral

No

Parenteral

No

Topical

No

Also known as

  • 18f-fluoromethyltyrosine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01297088Phase 1May 1, 2011Bayer, Piramal
NCT01089998Phase 1May 1, 2010Bayer, Piramal
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
BayerFor profit2012010
PiramalFor profit2212010
2 organizations
Page 1 / 1